financetom
Business
financetom
/
Business
/
Agios Pharmaceuticals Shares Down After Q1 Net Loss Widens, Revenue Misses Estimates
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Agios Pharmaceuticals Shares Down After Q1 Net Loss Widens, Revenue Misses Estimates
May 25, 2025 11:27 PM

10:32 AM EDT, 05/01/2025 (MT Newswires) -- Agios Pharmaceuticals ( AGIO ) shares were down 0.4% in recent trading Thursday after the company reported a Q1 net loss of $1.55 per diluted share, wider than a loss of $1.45 a year earlier.

Analysts polled by FactSet expected a loss of $1.77.

Revenue for the quarter ended March 31 was $8.7 million, up from $8.2 million a year earlier.

Analysts polled by FactSet expected $9.7 million.

As of March 31, the company said it had $1.42 billion in cash, cash equivalents and marketable securities.

Price: 29.58, Change: -0.11, Percent Change: -0.37

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved